Full Press Release Details
Thompson, President and CEO of Oncolytics Biotech Inc., certify the
Ball, CFO of Oncolytics Biotech Inc., certify the following:
ONCY
Q1 2009 CERTIFICATIONS exhibit99.htm FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Brad Thompson, President and CEO of Oncolytics Biotech Inc., certify the following: 1. Review: I have reviewed the i
Key Takeaway: Thompson, President and CEO of Oncolytics Biotech Inc., certify the
Ball, CFO of Oncolytics Biotech Inc., certify the following:
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+48%
120-day peak, hindsight
Typical move
7%
average across 3 past catalysts
Cash runway
~1 mo
High dilution risk
Lead asset
REOLYSIN
Phase 3 · Carcinoma, Squamous Cell of the Head and Neck